T-cell large granular lymphocyte leukemia laboratory findings: Difference between revisions
No edit summary |
|||
(2 intermediate revisions by one other user not shown) | |||
Line 8: | Line 8: | ||
===Immunophenotype=== | ===Immunophenotype=== | ||
The neoplastic cells of this disease display a mature [[T-cell]] [[immunophenotype]], with the majority of cases showing a [[CD4]]-/[[CD8]]+ T-cell subset [[immunophenotype]] versus other permutations of those markers. | The neoplastic cells of this disease display a mature [[T-cell]] [[immunophenotype]], with the majority of cases showing a [[CD4]]-/[[CD8]]+ T-cell subset [[immunophenotype]] versus other permutations of those markers. Variable expression of [[CD11b]], [[CD56]], and [[CD57]] are observed. Immunohistochemisty for [[perforin]], [[TIA-1]], and [[granzyme B]] are usually positive. | ||
{| border="1" cellpadding="5" cellspacing="0" | {| border="1" cellpadding="5" cellspacing="0" | ||
Line 27: | Line 27: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Hematology|T-cell large granular lymphocyte leukemia]] | |||
[[Category:Types of cancer|T-cell large granular lymphocyte leukemia]] |
Latest revision as of 16:43, 30 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
T-cell large granular lymphocyte leukemia Microchapters |
Differentiating T-cell large granular lymphocyte leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell large granular lymphocyte leukemia laboratory findings On the Web |
American Roentgen Ray Society Images of T-cell large granular lymphocyte leukemia laboratory findings |
FDA on T-cell large granular lymphocyte leukemia laboratory findings |
CDC on T-cell large granular lymphocyte leukemia laboratory findings |
T-cell large granular lymphocyte leukemia laboratory findings in the news |
Blogs on T-cell large granular lymphocyte leukemia laboratory findings |
Risk calculators and risk factors for T-cell large granular lymphocyte leukemia laboratory findings |
Overview
Laboratory Findings
- Complete blood count and differential count - neutropenia, anemia, lymphocytosis (in the range of 2-20x109/L)
- Immunoglobulin derangements including hypergammaglobulinemia, autoantibodies, and circulating immune complexes are commonly seen.[1][2][3]
Immunophenotype
The neoplastic cells of this disease display a mature T-cell immunophenotype, with the majority of cases showing a CD4-/CD8+ T-cell subset immunophenotype versus other permutations of those markers. Variable expression of CD11b, CD56, and CD57 are observed. Immunohistochemisty for perforin, TIA-1, and granzyme B are usually positive.
Type | Immunophenotype |
---|---|
Common type (80% of cases) | CD3+, TCRαβ+, CD4-, CD8+ |
Rare variants | CD3+, TCRαβ+, CD4+, CD8- |
CD3+, TCRαβ+, CD4+, CD8+ | |
CD3+, TCRγδ+, CD4 and CD8 variable |
References
- ↑ Oshimi K, Yamada O, Kaneko T; et al. (1993). "Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders". Leukemia. 7 (6): 782–8. PMID 8388971. Unknown parameter
|month=
ignored (help) - ↑ Loughran TP, Starkebaum G, Aprile JA (1988). "Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia". Blood. 71 (3): 822–4. PMID 3345349. Unknown parameter
|month=
ignored (help) - ↑ Loughran TP, Kadin ME, Starkebaum G; et al. (1985). "Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia". Ann. Intern. Med. 102 (2): 169–75. PMID 3966754. Unknown parameter
|month=
ignored (help)